Among them, the cyclin D-cyclin dependent kinase 4/6-inhibitor of CDK4-retinoblastoma (cyclinD-CDK4/6-INK4-RB) is an essential pathway for cancer cells to modulate G1 to S, which is important for many cancer types’ initiation, development, and survival (20, 21). This evidence concerns the gene CDK4 and cancer.